Literature DB >> 9462453

Melatonin receptors mediate contraction of a rat cerebral artery.

M Viswanathan1, E Scalbert, P Delagrange, B Guardiola-Lemaître, J M Saavedra.   

Abstract

Melatonin receptors are expressed in the cerebral arteries of the rat which form the circle of Willis. We report here that melatonin induces contraction of in vitro preparations of pressurized rat posterior communicating artery, in a concentration-dependent manner. This action of melatonin is inhibited by S-20928, a specific melatonin receptor antagonist. Our results demonstrate that the contractile action of melatonin is mediated by its receptors in the cerebral artery, and suggest a role for melatonin in the regulation of cerebral circulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9462453     DOI: 10.1097/00001756-199712220-00002

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  8 in total

1.  International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.

Authors:  Margarita L Dubocovich; Philippe Delagrange; Diana N Krause; David Sugden; Daniel P Cardinali; James Olcese
Journal:  Pharmacol Rev       Date:  2010-07-06       Impact factor: 25.468

2.  MT2 receptors mediate the inhibitory effects of melatonin on nitric oxide-induced relaxation of porcine isolated coronary arteries.

Authors:  Radhika R Tunstall; Praveen Shukla; Anna Grazul-Bilska; Chengwen Sun; Stephen T O'Rourke
Journal:  J Pharmacol Exp Ther       Date:  2010-10-19       Impact factor: 4.030

3.  New selective ligands of human cloned melatonin MT1 and MT2 receptors.

Authors:  Valérie Audinot; François Mailliet; Chantal Lahaye-Brasseur; Anne Bonnaud; Aude Le Gall; Christophe Amossé; Sandra Dromaint; Marianne Rodriguez; Nadine Nagel; Jean-Pierre Galizzi; Benoît Malpaux; Gérald Guillaumet; Daniel Lesieur; François Lefoulon; Pierre Renard; Philippe Delagrange; Jean A Boutin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-05-23       Impact factor: 3.000

4.  Melatonin inhibits nitric oxide signaling by increasing PDE5 phosphorylation in coronary arteries.

Authors:  Praveen Shukla; Chengwen Sun; Stephen T O'Rourke
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-10-19       Impact factor: 4.733

5.  Aerobic exercise enhanced endothelium-dependent vasorelaxation in mesenteric arteries in spontaneously hypertensive rats: the role of melatonin.

Authors:  Fang Qiu; Xiaodong Liu; Yanyan Zhang; Ying Wu; Daliao Xiao; Lijun Shi
Journal:  Hypertens Res       Date:  2018-07-02       Impact factor: 3.872

6.  Mechanisms of melatonin-induced vasoconstriction in the rat tail artery: a paradigm of weak vasoconstriction.

Authors:  M J Lew; S Flanders
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

Review 7.  Melatonin for cognitive impairment.

Authors:  S L Jansen; D A Forbes; V Duncan; D G Morgan
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

8.  Expression of Melatonin Receptor 1 in Rat Mesenteric Artery and Perivascular Adipose Tissue and Vasoactive Action of Melatonin.

Authors:  Lubos Molcan; Andreas Maier; Anna Zemančíková; Katharina Gelles; Jozef Török; Michal Zeman; Isabella Ellinger
Journal:  Cell Mol Neurobiol       Date:  2020-07-30       Impact factor: 5.046

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.